SEARCH

SEARCH BY CITATION

References

  • Andersen, P. H.: The dopamine inhibitor GBR 12909: selectivity and molecular mechanism of action. Eur. J. Pharmacol. 1989, 166, 493504.
  • Arbuthnott, G. W., I. S. Fairbrother & S. P. Butcher: Dopamine release and metabolism in the rat striatum; an analysis by in vivo brain dialysis. Pharmacol. Therap. 1990, 48, 281293.
  • Baldessarini, R. J.: Drugs and the treatment of psychiatric disorders. In: The pharmacological basis of therapeutics. Eds.: A. G.Gilman, L. S.Goodman, T. W.Rall & F.Murad. MacMillan Press, New York, 1985, pp. 387445.
  • Cadoni, C., A. Pinna, G. Russi, S. Consolo & G. Dichiara: Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: evidence from microdialysis and fos immunohistochemistry. Neuroscience 1995, 65, 10271039.
  • Da Prada, M., H. H. Keller, L. Pieri, R. Kettler & W. E. Haefely: The pharmacology of Parkinson's disease: basic aspects and recent advances. Experientia 1984, 40, 11651172.
  • Eshleman, A. J., E. Stewart, A. K. Evenson, J. N. Mason, R. D. Blakely, A. Janowsky & K. A. Neve: Metabolism of catecholamines by catechol-O-methyltransferase in cells expressing recombinant catecholamine transporters. J. Neurochem. 1997, 69, 14591466.
  • Fahn, S.: ‘On-off’ phenomenon with levodopa therapy in parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine. Neurology 1974, 24, 431441.
  • Gainetdinov, R. R., T. V. Grekhova, T. D. Sotnikova & K. S. Rayevsky: Dopamine D-2 and D-3 receptor preferring antagonists differentially affect striatal dopamine release and metabolism in conscious rats. Eur. J. Pharmacol. 1994, 261, 327331.
  • Hardie, R. J., S. L. Malcolm, A. J. Lees, G. M. Stern & J. G. Allen: The pharmacokinetics of intravenous and oral levodopa in patients with Parkinson's disease who exhibit on-off fluctuations. Brit. J. Clin. Pharmacol. 1986, 22, 429436.
  • Kaakkola, S. & R. J. Wurtman: Effects of COMT inhibitors on striatal dopamine metabolism: a microdialysis study. Brain Res. 1992, 587, 241249.
  • Kaakkola, S. & R. J. Wurtman: Effects of COMT inhibitors and L-dopa with and without carbidopa on extracellular dopamine in the rat striatum. J. Neurochem. 1993, 60, 137144.
  • Kaakkola, S., P. T. Männistö & E. Nissinen: Striatal membrane-bound and soluble catechol-O-methyltransferase after selective neural lesions in the rat. J. Neural Transm. [Gen. Sect.] 1987, 69, 221228.
  • Karhunen, T., C. Tilgmann, I. Ulmanen & P. Panula: Catechol-O-methyltransferase (COMT) in rat brain: immunoelectron microscopic study with an antiserum against rat recombinant COMT protein. Neurosci. Lett. 1995, 187, 5760.
  • Kask, A., J. Harro, P. Tuomainen, L. Rägo & P. T. Männistö: Overflow of noradrenaline and dopamine in frontal cortex after [N-(chloroethyl)-N-ethyl-2- bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 1997, 355, 267272.
  • Kehr, W.: 3-Methoxytyramine as an indicator of impulse-induced dopamine release in rat striatum in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. 1976, 293, 209215.
  • Kehr, W.: 3-Methoxytyramine and normetanephrine as indicators of dopamine and noradrenaline release in mouse brain in vivo. J. Neural Transm. [Gen. Sect.] 1981, 50, 165178.
  • Kopin, I.: Catecholamine metabolism: basic aspects and clinical significance. Pharmacol. Rev. 1985, 37, 333364.
  • Kuruma, I., G. Bartholini, R. Tissot & A. Pletscher: Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats. J. Pharm. Pharmacol. 1972, 24, 289294.
  • Lundström, K., J. Tenhunen, C. Tilgmann, T. Karhunen, P. Panula & I. Ulmanen: Cloning, expression and structure of catechol-O-methyltransferase. BBA-Prot. Struct. Mol. Enzymol. 1995, 1251, 110.
  • Männistö, P. T., P. Tuomainen & R. K. Tuominen: Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat. Brit. J. Pharmacol. 1992a, 105, 569574.
  • Männistö, P. T., I. Ulmanen, K. Lundström, J. Taskinen, J. Tenhunen, C. Tilgmann & S. Kaakkola: Characteristics of catechol O-methyltransferase (COMT) and properties of selective COMT inhibitors. Prog. Drug Res. 1992b, 39, 291350.
  • Messiha, F. S., T. H. Hsu & J. R. Bianchine: Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. J. Clin. Invest. 1972, 51, 452455.
  • Parry, T. J., T. L. Carter & J. G. McElligott: Physical and chemical considerations in the in vitro calibration of microdialysis probes for biogenic amine neurotransmitters and metabolites. J. Neurosci. Methods 1990, 32, 175183.
  • Paxinos, G. & C. Watson: The rat brain in stereotaxic coordinates. Academic Press, London, 1982.
  • Reilly, D. K., L. Rivera-Calimlim & D. Van Dyke: Catechol-O-methyltransferase activity: a determinant of levodopa response. Clin. Pharmacol. Therap. 1980, 28, 278286.
  • Rivera-Calimlim, L., D. Tandon, F. Anderson & R. Joynt: The clinical picture and plasma levodopa metabolite profile of Parkinsonian nonresponders. Treatment with levodopa and decarboxylase inhibitor. Arch. Neurol. 1977, 34, 228232.
  • Sokoloff, P., M. Andrieux, R. Besancon, C. Pilon, M. P. Martres, B. Giros & J. C. Schwartz: Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. Eur. J. Pharmacol. 1992, 225, 331337.
  • Svensson, K., S. Hjorth, D. Clark, A. Carlsson, H. Wikström, B. Andersson, D. Sanchez, A. M. Johansson, L. E. Arvidsson & U. Hacksell: (+)-UH 232 and (+)-UH 242: novel stereoselective dopamine receptor antagonists with preferential action on auto-receptors. J. Neural Transm. [Gen. Sect.] 1986, 65, 127.
  • Törnwall, M. & P. T. Männistö: Effects of three types of catechol O-methylation inhibitors on L-3,4-dihydroxyphenylalanine-induced circling behaviour in rats. Eur. J. Pharmacol. 1993, 250, 7784.
  • Törnwall, M., P. Tuomainen & P. T. Männistö: Modulation of rat brain endogenous dopamine metabolism by new inhibitors of catechol O-methyltransferase. Eur. J. Pharmacol. 1993, 239, 3945.
  • Törnwall, M., S. Kaakkola, P. Tuomainen, A. Kask & P. T. Männistö: Comparison of two new inhibitors of catechol O-methyltransferase on striatal dopamine metabolism: a microdialysis study in rats. Brit. J. Pharmacol. 1994, 112, 1318.
  • Trendelenburg, U.: The interaction of transport mechanisms and intracellular enzymes in metabolizing systems. J. Neural Transm. [Suppl.] 1990, 32, 318.
  • Tuomainen, P., M. Törnwall & P. T. Männistö: Minor effect of tolcapone, a catechol- O-methyltransferase inhibitor, on extracellular dopamine levels modified by amphetamine or pargyline: a microdialysis study in anaesthetized rats. Pharmacology & Toxicology 1996, 78, 392396.
  • Wood, P. I. & C. A. Altar: Dopamine release in vivo from nigrostriatal, mesolimbic, and mesocortical neurons: utility of 3-methoxy-tyramine measurements. Pharmacol. Rev. 1988, 40, 163187.